RecruitingEarly Phase 1NCT05700916
Evaluation of Milk Polar Lipids in Dyslipidemic Adults With Abdominal Obesity
Evaluation of Milk Polar Lipids on Lipoprotein Metabolism, Inflammation, and Gut Microbiota in Dyslipidemic Adults With Abdominal Obesity
Sponsor
University of Connecticut
Enrollment
130 participants
Start Date
Oct 20, 2023
Study Type
INTERVENTIONAL
Conditions
Summary
The major objective of this project is to examine whether daily consumption of milk polar lipids (MPLs) influences cardiometabolic risk factors.
Eligibility
Min Age: 18 YearsMax Age: 70 Years
Inclusion Criteria3
- LDL-C ≥ 130 mg/dL
- Waist circumference ≥ 88 cm for women, ≥ 102 cm for men
- Aged 18 to 70 years
Exclusion Criteria23
- Renal disease
- Liver disease
- Diabetes
- Heart disease
- Stroke
- Cancer
- Eating disorders
- Thyroid disease
- Gut-associated pathologies
- Autoimmune diseases
- Chronic inflammatory diseases
- Scleroderma
- Gallbladder disease
- Blood clotting disorders
- Intravenous drug use
- Fasting plasma/serum triglycerides >500 mg/dL
- Fasting plasma/serum glucose >126 mg/d
- Weight changes >10% over last 4 weeks
- Oral antibiotics use up to 1 month prior to and during study
- Allergy or intolerance to milk products
- Taking lipid-lowering medications (e.g., statins, fibrates)
- Taking anti-inflammatory medications (e.g., corticosteroids)
- Taking medications which primarily affect blood clotting (e.g., warfarin).
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGMilk Polar Lipid-Rich Dairy Powder
Effects of the addition of 6.5 g of milk polar lipids to dairy powder.
DIETARY_SUPPLEMENTDairy Powder
Effects of dairy control powder
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05700916
Related Trials
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
NCT0667254950 locations
A Study of Tirzepatide (LY3298176) in Adult Participants in India With Either Type 2 Diabetes Mellitus or Obesity
NCT0743844421 locations
A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)
NCT0643927773 locations
A Study of LY4086940 in Healthy Participants and Participants With Overweight or Obesity, With or Without Type 2 Diabetes
NCT069454195 locations
Youth-Onset Type 2 Diabetes and Heart Disease: The Young at Heart Prospective Cohort Study
NCT067301132 locations